MUFG Securities EMEA plc

Broker-Dealer

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1597694 LONDON, X0

Position in REGN

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$13,236,868

+$10,047,502 QoQ

Shares Held

17,132

+314.6% QoQ

Ownership

0.016%

of shares outstanding

% of Portfolio

0.20%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

MUFG Securities EMEA plc holds $31,265,233 across 8 Biotechnology names. REGN ranks #1 (42.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc. This page	17,132	$13,236,868
2	ROIV	Roivant Sciences Ltd.	200,000	$5,540,000
3	RVMD	Revolution Medicines, Inc.	49,043	$4,769,431
4	VRTX	Vertex Pharmaceuticals Inc / Ma	10,413	$4,649,821
5	FTRE	Fortrea Holdings Inc.	145,000	$1,365,900
6	MRNA	Moderna, Inc.	14,212	$721,969
7	INCY	Incyte Corp	6,853	$645,004
8	TECH	BIO-TECHNE Corp	6,434	$336,240

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$13,236,868	17,132	+314.6%	Shares	Defined	2026-05-11
2025-12-31	$3,189,366	4,132	+111.9%	Shares	Defined	2026-02-10
2025-09-30	$1,096,426	1,950	+535.2%	Shares	Sole	2025-11-14
2025-06-30	$161,175	307	+127.4%	Shares	Sole	2025-10-07
2022-09-30	$92,997	135	0.0%	Shares	Sole	2022-11-09
2022-06-30	$79,802	135	0.0%	Shares	Sole	2022-08-15
2022-03-31	$94,286	135	0.0%	Shares	Sole	2022-05-18
2021-12-31	$85,255	135	0.0%	Shares	Sole	2022-02-11
2021-09-30	$81,699	135	-82.7%	Shares	Sole	2021-11-12
2021-06-30	$435,661	780	-72.9%	Shares	Sole	2021-07-19
2021-03-31	$1,362,643	2,880	+144.1%	Shares	Sole	2021-05-11
2020-12-31	$570,069	1,180	+90.0%	Shares	Sole	2021-02-11
2020-09-30	$347,623	621	-51.5%	Shares	Sole	2020-11-13
2020-03-31	$625,011	1,280	—	Shares	Sole	2020-05-12
No filing history on record for this holder in this stock.